AIT Therapeutics Reports Positive Top Line Results from its Nitric Oxide in Bronchiolitis (NO-BRO) Pilot Study in Infants

World News: . []

NEW YORK June 13 2018 GLOBE NEWSWIRE -- AIT Therapeutics Inc OTCAITB a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide NO for the treatment of patients with respiratory conditions includi...

More news and information about AIT Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Wednesday 13th June 2018

Published: .

Search for other references to "therapeutics" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us